Fexuprazan Hydrochloride
CAS No : 1902954-87-3
General description:
Fexuprazan Hydrochloride is an active pharmaceutical ingredient (API) used in the treatment of acid-related gastrointestinal disorders, including gastroesophageal reflux disease (GERD). It belongs to the class of potassium-competitive acid blockers (P-CABs) and works by reversibly inhibiting the gastric H⁺/K⁺-ATPase enzyme, resulting in rapid and sustained suppression of gastric acid secretion.
Fexuprazan Hydrochloride is manufactured under stringent quality and regulatory standards to ensure high purity, consistent potency, and reliable performance. The hydrochloride salt form enhances stability and suitability for formulation development, clinical research, and commercial pharmaceutical manufacturing of anti-ulcer and acid-suppressive therapies.
Fexuprazan Hydrochloride is manufactured under stringent quality and regulatory standards to ensure high purity, consistent potency, and reliable performance. The hydrochloride salt form enhances stability and suitability for formulation development, clinical research, and commercial pharmaceutical manufacturing of anti-ulcer and acid-suppressive therapies.
Chemical Structure:
